Cingulate Inc. - CING

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.22M
QoQ value delta ($000)
+$1.086M (+95.77%)
Implied price effect (QoQ)
+10.71%
Shares
Total shares
513,369
QoQ shares delta
+223,041 (+76.82%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CING)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 34 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 657 151,433 0.0%
Kestra Advisory Services, LLC 529 122,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 264 61,035 0.0%
DRW Securities, LLC 254 58,672 0.01%
UBS Group AG 120 27,684 0.0%
XTX Topco Ltd 90 20,742 0.0%
Quadrature Capital Ltd 65 15,182 0.0%
NORTHERN TRUST CORP 59 13,622 0.0%
LPL Financial LLC 46 10,600 0.0%
Soltis Investment Advisors LLC 43 10,000 0.0%
Quantum Private Wealth, LLC 43 10,000 0.01%
BANK OF AMERICA CORP /DE/ 31 7,341 0.0%
HARBOUR INVESTMENTS, INC. 9 2,275 0.0%
MORGAN STANLEY 4 1,000 0.0%
Tower Research Capital LLC (TRC) 3 871 0.0%
OSAIC HOLDINGS, INC. 3 868 0.0%
SHP Wealth Management 0 43 0.0%
SBI Securities Co., Ltd. 0 1 0.0%